904 - Tariffs on Pharmaceuticals
Public Health On Call
The Johns Hopkins Bloomberg School of Public Health
4.8 • 620 Ratings
🗓️ 9 June 2025
⏱️ 14 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Summary
About this episode:
Would it be a good idea to have tariffs on pharmaceuticals? In this episode: a conversation about the rationales for tariffs as well as potential downsides—like higher drug prices—and what could really help with supply and pricing issues.
Guest:
Dr. Mariana Socal studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health.
Host:
Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland’s Health Department.
Show links and related content:
-
Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains—Johns Hopkins Carey Business School
-
Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages—NBC Los Angeles
Transcript information:
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
-
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health, |
| 0:05.9 | where we bring evidence, experience, and perspective to make sense of today's leading health challenges. |
| 0:16.3 | If you have questions or ideas for us, please send an email to public health question at jhhhu.edu. |
| 0:23.8 | That's public health question at jhhu.edu for future podcast episodes. |
| 0:30.9 | It's Lindsay Smith Rogers. |
| 0:32.9 | Today, would it be a good idea to have tariffs on pharmaceuticals? |
| 0:37.7 | Dr. Mariana SoCal is a Johns Hopkins faculty member who studies the pharmaceutical market. |
| 0:43.1 | She talks with Dr. Josh Sharfstein about the possible rationale for tariffs and the potential |
| 0:48.7 | downsides, including higher drug prices. |
| 0:51.8 | Let's listen. |
| 0:53.0 | Dr. Mariana Socal, thank you so much for joining me today in Public Health on Call to talk |
| 0:57.9 | about tariffs on pharmaceuticals. How are you doing today? |
| 1:01.6 | Thank you so much for having me. It's a pleasure to be here. |
| 1:05.1 | Do you just introduce yourself to our audience and what you study here at Johns Hopkins? |
| 1:09.8 | Certainly. My name is Mariana Soquel. |
| 1:11.9 | I'm an associate professor of health policy and management |
| 1:14.5 | at the Johns Hopkins Bloomberg School of Public Health. |
| 1:18.4 | And I research all things related to pharmaceutical policy, |
| 1:22.2 | primarily access, affordability, pricing, |
| 1:24.7 | and also supply of pharmaceuticals. |
| 1:27.5 | So that brings us to our topic. |
| 1:29.8 | President Trump has been talking a lot about tariffs these days, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.